Immucor Announces FDA Clearance of NEO

Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced that its fourth generation automated instrument, NEO, has been cleared for marketing in the U.S. by the Food and Drug Administration (FDA)
Breitbart